Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Fiji is experiencing significant growth and development.
Customer preferences: Customers in Fiji have shown a growing demand for treatments and therapies related to depressive disorders. They are increasingly seeking professional help and are more open to discussing mental health issues. This shift in customer preferences can be attributed to the increasing awareness and understanding of mental health in the country.
Trends in the market: One of the key trends in the Depressive Disorders market in Fiji is the rise in the number of mental health professionals and facilities. The government has been actively investing in the healthcare sector, including mental health services, which has led to an increase in the availability and accessibility of treatment options for depressive disorders.Another trend in the market is the growing adoption of telemedicine and online therapy services. This trend has been accelerated by the COVID-19 pandemic, which has limited in-person consultations. Online therapy platforms have become popular among customers, offering convenience and flexibility in accessing mental health support.
Local special circumstances: Fiji, being an island nation, has unique challenges when it comes to providing healthcare services. The geographical dispersion of the population and limited infrastructure in remote areas can make it difficult for individuals to access mental health services. As a result, there has been a focus on expanding mental health services to rural and remote areas, including the use of mobile clinics and outreach programs.
Underlying macroeconomic factors: Fiji has been experiencing steady economic growth in recent years, which has contributed to an increase in healthcare spending. The government has recognized the importance of investing in mental health services and has allocated resources to improve the quality and accessibility of care for individuals with depressive disorders.Furthermore, the tourism industry in Fiji plays a significant role in the country's economy. The influx of tourists has led to an increase in the demand for mental health services, as individuals may experience stress or anxiety while traveling. This has created opportunities for the growth of the Depressive Disorders market, with specialized services catering to tourists.In conclusion, the Depressive Disorders market in Fiji is witnessing growth and development due to changing customer preferences, increasing investment in mental health services, the adoption of telemedicine, and the unique circumstances of the island nation. The government's focus on expanding healthcare services to rural areas and the economic growth of Fiji are also contributing factors to the market's growth.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights